Target Synonym: IMD;MGC;CTLA;CANDF;CDw;IL17RA;CANDF5;CD217;CDw217;IL-17RA;IL17R;IMD51;hIL-17R;CD127;CD217 antigen;CDW127;CTLA8;HIL 17R;hIL17R;I17RA;IL 17 receptor;IL 17 receptor A;IL 17RA;IL17;IL-17 R alpha;IL-17 receptor A;IL17A receptor;IL-17R;IL17R-A;IL17-RA;IL-17R-alpha;IL7RA;ILRA;Interleukin 17 receptor A;Interleukin-17 receptor A;MGC10262;CDw217;Interleukin-17 receptor A
Background: Interleukin 17 (also known as CTLA-8) is a T cell-expressed pleotropic cytokine. IL-17 binds to IL-17 receptor A (IL-17 RA), also known as IL-17 receptor (IL-17 R). IL-17 RA shares no homology with any known family of receptors. While the expression of IL-17 is restricted to activated T cells, the IL-17 RA mRNA exhibits a broad tissue distribution, and has been detected in virtually all cells and tissues tested. Human IL-17 RA is a 120 kDa, 866 amino acid (aa) type I membrane glycoprotein with a 293 aa extracellular domain, a 21 aa carboxy-proximal transmembrane domain, and a 525 aa cytoplasmic tail. Within the ECD, human IL-17 RA shares 72% aa sequence identity with mouse and rat IL-17 RA. The signaling events of IL-17 includes activation of NF-kappa B and JNK, and require TNF receptor-associated factors 6 (TRAF6) in the signaling pathway.
Immunogen: Recombinant Human IL17RA protein
Buffer: 0.2 μm filtered solution in PBS
Dilution: WB 1:500-1:1000;
Calculated MW: 96 kDa
Observed MW: 105 kDa
Deutsch
English
